Viewing Study NCT01502592


Ignite Creation Date: 2025-12-24 @ 3:45 PM
Ignite Modification Date: 2026-06-10 @ 5:25 PM
Study NCT ID: NCT01502592
Status: COMPLETED
Last Update Posted: 2016-01-05
First Post: 2011-12-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Invasive Adenocarcinoma of the Breast View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MDX-010 (Ipilimumab) View
None Cryoablation View
None Total mastectomy planned View
None 11-202 View